Hexavest’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-6,775
| Closed | -$104K | – | 428 |
|
|
2018
Q4 | $104K | Buy |
+6,775
| New | +$104K | ﹤0.01% | 263 |
|
|
2017
Q4 | – | Sell |
-319,710
| Closed | -$5.63M | – | 492 |
|
|
2017
Q3 | $5.63M | Sell |
319,710
-2,522
| -0.8% | -$44.4K | 0.07% | 188 |
|
|
2017
Q2 | $10.7M | Buy |
322,232
+1,198
| +0.4% | +$39.8K | 0.14% | 150 |
|
|
2017
Q1 | $10.3M | Buy |
321,034
+310,215
| +2,867% | +$9.95M | 0.12% | 153 |
|
|
2016
Q4 | $392K | Buy |
10,819
+1,715
| +19% | +$62.1K | 0.01% | 257 |
|
|
2016
Q3 | $419K | Sell |
9,104
-2,850
| -24% | -$131K | 0.01% | 263 |
|
|
2016
Q2 | $600K | Sell |
11,954
-3,679
| -24% | -$185K | 0.01% | 270 |
|
|
2016
Q1 | $837K | Sell |
15,633
-725
| -4% | -$38.8K | 0.01% | 250 |
|
|
2015
Q4 | $1.07M | Buy |
16,358
+4,280
| +35% | +$281K | 0.02% | 235 |
|
|
2015
Q3 | $682K | Sell |
12,078
-968
| -7% | -$54.7K | 0.01% | 242 |
|
|
2015
Q2 | $771K | Hold |
13,046
| – | – | 0.01% | 250 |
|
|
2015
Q1 | $813K | Hold |
13,046
| – | – | 0.01% | 232 |
|
|
2014
Q4 | $750K | Sell |
13,046
-8,550
| -40% | -$492K | 0.01% | 232 |
|
|
2014
Q3 | $1.16M | Hold |
21,596
| – | – | 0.02% | 232 |
|
|
2014
Q2 | $1.13M | Buy |
21,596
+945
| +5% | +$49.5K | 0.02% | 229 |
|
|
2014
Q1 | $1.09M | Buy |
20,651
+10,400
| +101% | +$549K | 0.02% | 222 |
|
|
2013
Q4 | $411K | Sell |
10,251
-200
| -2% | -$8.02K | 0.01% | 262 |
|
|
2013
Q3 | $395K | Buy |
10,451
+7,000
| +203% | +$265K | 0.01% | 272 |
|
|
2013
Q2 | $135K | Buy |
+3,451
| New | +$135K | ﹤0.01% | 296 |
|